Randomized phase II study of first-line carboplatin-paclitaxel with or without bevacizumab in Japanese patients with advanced non-squamous non-small-cell lung cancer
Keywords: Non-small cell lung cancer; Bevacizumab; Carboplatin; Paclitaxel; Advanced lung cancer; Chemonaïve;